Condensed Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 28, 2014	Jun. 29, 2013	Jun. 28, 2014	Jun. 29, 2013
Net sales	$ 1,448	$ 1,403	$ 2,811	$ 2,741
Cost of sales:
Cost of sales before special charges	407	381	789	740
Special charges	26	1	27	19
Total cost of sales	433	382	816	759
Gross profit	1,015	1,021	1,995	1,982
Selling, general and administrative expense	523	489	988	957
Research and development expense	178	173	348	333
Special charges	25	77	58	102
Operating profit	289	282	601	590
Other expense, net	21	183	41	231
Earnings before income taxes and noncontrolling interest	268	99	560	359
Income tax expense (benefit)	22	(8)	75	30
Net earnings before noncontrolling interest	246	107	485	329
Less: Net loss attributable to noncontrolling interest	(24)	(8)	(34)	(9)
Net earnings attributable to St. Jude Medical, Inc.	$ 270	$ 115	$ 519	$ 338
Net earnings per share attributable to St. Jude Medical, Inc.:
Basic	$ 0.95	$ 0.41	$ 1.83	$ 1.19
Diluted	$ 0.93	$ 0.40	$ 1.80	$ 1.18
Cash dividends declared per share:	$ 0.27	$ 0.25	$ 0.54	$ 0.50
Weighted average shares outstanding:
Basic	284.2	283.9	284.3	284.6
Diluted	288.9	286.7	289.1	287.1